REMAX
Price
$20.64
Change
-$0.17 (-0.82%)
Updated
Oct 7 closing price
Net Assets
835.45M
RNWHX
Price
$94.70
Change
-$0.31 (-0.33%)
Updated
Oct 7 closing price
Net Assets
75.16B
Interact to see
Advertisement

REMAX vs RNWHX

Header iconREMAX vs RNWHX Comparison
Open Charts REMAX vs RNWHXBanner chart's image
Russell Inv Emerging Markets A
Price$20.64
Change-$0.17 (-0.82%)
VolumeN/A
Net Assets835.45M
American Funds New World R5E
Price$94.70
Change-$0.31 (-0.33%)
VolumeN/A
Net Assets75.16B
REMAX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
REMAX vs. RNWHX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REMAX is a Hold and RNWHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 75.2B vs. REMAX (835M). REMAX pays higher dividends than RNWHX: REMAX (1.83) vs RNWHX (0.93). REMAX was incepted earlier than RNWHX: REMAX (19 years) vs RNWHX (10 years). REMAX (1.56) is less costly to investors than RNWHX (0.72). REMAX is a more actively managed with annual turnover of: 66.00 vs. RNWHX (37.00). REMAX has a lower initial minimum investment than RNWHX: REMAX (0) vs RNWHX (250). REMAX annual gain was more profitable for investors over the last year : 19.73 vs. RNWHX (12.65). RNWHX return over 5 years is better than : 30.19 vs. REMAX (20.07).
REMAXRNWHXREMAX / RNWHX
Total Expense Ratio1.440.72200%
Annual Report Gross Expense Ratio1.560.72217%
Fund Existence19 years10 years-
Gain YTD31.62624.572129%
Front Load6%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets835M75.2B1%
Annual Yield % from dividends1.830.93197%
Returns for 1 year19.7312.65156%
Returns for 3 years61.9457.51108%
Returns for 5 years20.0730.1966%
Returns for 10 years48.49N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGX2.950.26
+9.67%
Metagenomi
MLTX9.280.62
+7.16%
MoonLake Immunotherapeutics
HCWB4.03N/A
N/A
HCW Biologics Inc
ACMR40.46-1.32
-3.16%
ACM Research
WSO396.34-13.65
-3.33%
Watsco